Our Sponsors

VIPCoFCCGBroadridgeLink Market Services GmbHAHEADhermesDP DHLK+SSAPGeorgesonSuedzuckerWacker Chemie AGThomson ReutersEQS Group

Search

VIPsight

Corporate Governance – portrayed in the individual cultural and legal framework, from the standpoint of equity capital.

VIPsight is a dynamic photo archive, sorted by nations and dates, by and for those interested in CG from all over the world.

VIPsight offers, every month:
transparent and independent current information / comments / facts and figures on corporate governance locally and internationally,

  • written by local CG experts,
  • selected and structured by the Club of Florence,
  • financed by its initiator VIP and other sponsors with a background of “Equity and Advisory” interests.
     

VIPsight International


Article Index

 

 

Capital News

 

Hello Fresh: fresh foodstuffs in the stock exchange

Hello Fresh, purveyor of foodstuffs ordered on line is hoping to get a stock market listing before the end of the year, according to Handelsblatt citing a source within the company. Hello Fresh does not provide precooked food but portions of fresh ingredients to make certain set dishes. The start-up with Rocket Internet as its majority shareholder is now selling approximately 4 million portions per month, not only in Germany but in Great Britain, the United States and Benelux, with an annual turnover of 120 million Euros. At the beginning of the year, when Rocket Internet added a further 100 million Euros , bringing its share quota to 42 percent, the company established in 2011 was still worth 624 million Euros . According to an internal source, the company could grow up to approximately one billion Euros.

 

4SC: financial assistance for research

Biotec concern 4SC AG launched two share capital events to increase its share capital from 10,2 to approximately 19 million Euros. In one event, with the right of option, the Prime Standard-listed company placed a total of 7.25 million Euros worth of new shares at 4 Euros each. The gross revenue of the issue – some 29 million Euros – will be used to fund R & D projects in the field of anti tumour drugs Within the other real share capital increase, 4SC issued 1.5 million shares at 4 Euros each, which will enable it to liquidate a substantial part of a shareholder loan of 6 million Euros.